Log in to your Inderes Free account to see all free content on this page.
IRLAB Therapeutics
1.60 SEK
-0.99 %
Less than 1K followers
IRLAB A
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for IRLAB Therapeutics
P/E
Median 2019-2025
EV/S
Median 2019-2024
EV/EBIT
Median 2019-2024
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 33.95 | 39.65 | 41.54 | 36.16 | 7.08 | 10.15 | 1.97 |
| Shares | 43.7 | 50.5 | 54.8 | 54.9 | 54.9 | 54.9 | 84.9 |
| Market cap | 1,482.1 | 2,002.4 | 2,276.9 | 1,986.6 | 389.0 | 557.6 | 167.3 |
| Enterprise value | 1,376.1 | 1,728.4 | 1,881.6 | 1,737.8 | 305.3 | 551.1 | - |
| EV/S | 52,928.2 | - | 9.1 | 28.4 | 53.7 | 5.8 | - |
| EV/EBITDA | neg. | neg. | 33.6 | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | 35.8 | neg. | neg. | neg. | - |
| P/E | neg. | neg. | 44.0 | neg. | neg. | neg. | neg. |
| P/B | 8.15 | 5.76 | 5.70 | 6.83 | 3.36 | 17.08 | 5.45 |
| P/S | 57,004.5 | - | 11.0 | 32.5 | 68.5 | 5.9 | 2.9 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 87.4 % | 94.0 % | 84.6 % | 89.9 % | 65.4 % | 24.0 % | 22.2 % |
| Gearing ratio | 2.5 % | 0.8 % | 1.7 % | 1.4 % | 23.8 % | 185.1 % | 97.5 % |
Login required
This content is only available for logged in users